Moors & Cabot’s HCA Healthcare HCA Stock Holding History

Moors & Cabot’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Sell	832 -33	-4%	-$14K	0.01%	721
2026 Q1	$410K	Sell	865 -66	-7%	-$33.2K	0.02%	601
2025 Q4	$435K	Buy	931 +23	+3%	+$10.7K	0.02%	581
2025 Q3	$387K	Buy	908 +12	+1%	+$4.65K	0.02%	599
2025 Q2	$343K	Buy	896 +38	+4%	+$13.7K	0.02%	611
2025 Q1	$297K	Buy	858 +39	+5%	+$12.5K	0.02%	647
2024 Q4	$246K	Hold	819	–	–	0.01%	729
2024 Q3	$333K	Hold	819	–	–	0.02%	633
2024 Q2	$263K	Sell	819 -4	-0.5%	-$1.3K	0.01%	671
2024 Q1	$275K	Hold	823	–	–	0.01%	703
2023 Q4	$223K	Buy	823 +4	+0.5%	+$989	0.01%	718
2023 Q3	$202K	Sell	819 -4	-0.5%	-$1.09K	0.01%	748
2023 Q2	$250K	Buy	823 +4	+0.5%	+$1.11K	0.02%	681
2023 Q1	$216K	Buy	+819	New	+$208K	0.01%	726
2022 Q2	–	Sell	-901	Closed	-$226K	–	859
2022 Q1	$226K	Hold	901	–	–	0.01%	733
2021 Q4	$232K	Buy	+901	New	+$220K	0.01%	730

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

CAM

Crake Asset Management London, United Kingdom $4.18B AUM 13.97% 1-Year Est. Return

Metropolis Capital Amersham, United Kingdom $3.45B AUM 1.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Moors & Cabot's HCA Position: Q2 2026 in Review

Moors & Cabot reduced its HCA Healthcare (HCA) stake by 3.8% in Q2 2026, selling an estimated $14K and leaving 832 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #721.

Moors & Cabot first reported a position in HCA in Q4 2021 and has held it in 16 quarters since. The position peaked at $435K in Q4 2025. 796 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Moors & Cabot held 832 shares of HCA Healthcare worth $325K as of Q2 2026.
Moors & Cabot sold 33 HCA Healthcare shares in Q2 2026, an estimated $14K.
HCA Healthcare made up 0.01% of Moors & Cabot's portfolio in Q2 2026, its #721 holding.
Moors & Cabot first reported a position in HCA Healthcare in Q4 2021 and has held it in 16 quarters since.
Moors & Cabot's HCA Healthcare position peaked at $435K in Q4 2025.
796 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.